New Scoring System for Assessing Hepatitis C Transmission Risk
Author Information
Author(s): Mark A Stoové, Craig L Fry, Nick Lintzeris
Primary Institution: Macfarlane Burnet Institute for Medical Research and Public Health
Hypothesis
The study examines the properties of a new weighted BBV-TRAQ designed to quantify HCV transmission risk among injecting drug users.
Conclusion
The weighted BBV-TRAQ enhances the utility of the questionnaire for community-based education and prevention of HCV transmission.
Supporting Evidence
- The weighted BBV-TRAQ produced promising predictive validity results among IDU based on self-report HCV status.
- Internal reliability for the total BBV-TRAQ was good, with a standardized item alpha of .89.
- Log five weighted scores were able to discriminate between HCV positive and negative IDU.
Takeaway
This study created a new way to measure how likely it is for people who use drugs to get hepatitis C, which can help in teaching them how to stay safe.
Methodology
Cross-sectional surveys of Australian injecting drug users were analyzed to generate normative data and explore the properties of a weighted BBV-TRAQ.
Potential Biases
Self-reporting may introduce bias in the accuracy of HCV status and risk behaviors.
Limitations
The study relied on self-reported HCV status, which may not be entirely accurate, and the cross-sectional design limits causal inferences.
Participant Demographics
{"percentage_male":57,"mean_age":27.8,"employment":{"employed":22,"unemployed":66},"mean_years_since_first_injection":9.5,"drug_most_injected":{"heroin":71,"amphetamines":22},"self_report_BBV_status":{"HCV_positive":45,"HCV_negative":42,"never_tested":13}}
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website